Canada Markets open in 2 hrs 27 mins

Mydecine Innovations Group Inc. (MYCO.NE)

NEO - NEO Real Time Price. Currency in CAD
Add to watchlist
0.7600-0.1300 (-14.61%)
At close: 03:59PM EDT
Full screen
Previous Close0.8900
Open0.8900
Bid0.7500 x N/A
Ask0.8500 x N/A
Day's Range0.7600 - 0.9000
52 Week Range0.6600 - 30.0000
Volume19,864
Avg. Volume51,488
Market Cap181.401M
Beta (5Y Monthly)4.06
PE Ratio (TTM)N/A
EPS (TTM)-0.1150
Earnings DateNov 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation

    DENVER, June 17, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology aiming to transform the treatment of mental health and addiction disorders, today announced that the U.S. Food and Drug Administration (FDA) has cleared MYCO-001 in a recent Investigational New Drug (IND) application, marking the first clearance of the Company’s drug product. The Investigator Initiated trial is funded by a near $4 million grant

  • GlobeNewswire

    Mydecine Provides Company Update; Welcomes New Board Member

    DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today provided an update on clinical trial and drug development initiatives, and appointed a new member to its Board of Directors. Corporate Update "As we near the end of the second quarter, I’m proud of the progress our team has made despite the volatile an

  • CNW Group

    Mydecine Announces Closing of Overnight Marketed Public Offering of Units

    Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that it has closed its previously announced best efforts overnight marketed offering (the "Offering") of units (the "Units") through a syndicate of agents led by Stifel Nicolaus Canada Inc. ("Stifel GMP") and Roth Canada, Inc. (together with Stifel GMP, the "Agents"). Under the Offering, the Company issued 2,447,130 Units at a price per Unit of $1.15 for aggregate gross proce